DMAC vs MSI · $157.4M cap vs P/E 33, rev $11.68B
DiaMedica Therapeutics Inc (DMAC) versus Motorola Solutions Inc (MSI) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Motorola Solutions Inc (MSI) is a communication equipment company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported MSI revenue for 2025-12-31 was $11.68B. Net income was $2.15B. Revenue was up 8.0% from 2024-12-31 to 2025-12-31. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
DMAC currently screens at market cap $157.4M. MSI currently screens at market cap $68.32B and trailing P/E 33.2.
Not investment advice. Open the DMAC and MSI stock pages for the full models.
Not investment advice.